PharmaMar’s Aplidin In The Spotlight Again As Top EU Court Sets Aside Earlier Ruling On Approval

 
• By Ian Schofield
  
Legal dispute
The EU courts are at odds over a cancer drug from PharmaMar • Source: Shutterstock

More from Europe

More from Geography